We report the longest duration of implantation of a porcine bioprosthesis in the English language literature--a Carpentier-Edwards valved conduit excised after twenty-five years. This 50-year-old man had undergone a modified Fontan operation for tricuspid atresia. He presented with progressive dyspnea, fatigue and edema. The bioprosthesis' dysfunction was due to the pathologic findings of pannus, significant thrombus (on the sinus surface of a cusp), mild structural valve deterioration and pseudo-intimal formation within the conduit. The bioprosthesis' longevity is likely related to low-pressure circulation in the right heart and to host tissue (pannus) overgrowth that covered the cusps and thereby reduced tissue degeneration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijcard.2006.07.063 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Navigating marginalized identities in diverse organizations.
Curr Opin Psychol
December 2024
University of Pretoria, South Africa.
People with marginalized identities must often manage the diversity dynamics that are activated by their presence in organizations. Due to underrepresentation and stigmatization, they cope with a range of identity threats while navigating diverse settings. A host of studies over the past twenty-five years have examined the wide range of verbal and nonverbal tactics that people use to suppress and express their devalued versus valued social identities at work.
View Article and Find Full Text PDFAdjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).
NPJ Breast Cancer
January 2025
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Optimal timing and dosing of adjuvant cyclin-dependent kinase (CDK) 4/6 inhibitor in early breast cancer is controversial. This prospective phase II clinical trial investigated tolerability and safety of two ribociclib dosing schedules. Patients with stage I-III hormone receptor-positive (HR+)/HER2- breast cancer on adjuvant endocrine therapy (ET) were randomized to two ribociclib dosing schedules: 400 mg continuous vs 600 mg intermittent, with initiation in early (prior ET < 2 years) vs delayed (prior ET ≥ 2 years) setting.
View Article and Find Full Text PDFIn Vitro Screening of an In-House Library of Structurally Distinct Chemotypes Towards the Identification of Novel SARS-CoV-2 Inhibitors.
Pharmaceuticals (Basel)
December 2024
Dipartimento di Scienze Biomediche Chirurgiche e Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133 Milano, Italy.
Four years after the COVID-19 pandemic, a very limited number of drugs has been marketed; thus, the search for new medications still represents a compelling need. In our previous work on antiviral, antiparasitic, and antiproliferative agents, we described several compounds (- and -) structurally related to clofazimine, chloroquine, and benzimidazole derivatives. Thus, we deemed it worthwhile to test them against the replication of SARS-CoV-2, together with a few other compounds (, and -), which showed some analogy to miscellaneous anti-coronavirus agents.
View Article and Find Full Text PDFImpact of Lower-Limb Asymmetries on Physical Performance Among Adolescent Female Tennis Players.
Life (Basel)
November 2024
Health Sciences Faculty, Universidad San Jorge, 50830 Zaragoza, Spain.
Unlabelled: This study aimed to determine the correlation between interlimb asymmetries and physical performance metrics in adolescent female tennis players.
Methods: Twenty-five female tennis players (age: 13.29 ± 0.
Surgical and Bronchoscopic Lung Volume Reduction for Severe Emphysema: A Systematic Review and Network Meta-analysis.
Lung
January 2025
Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
Article Synopsis
- The systematic review examines surgical and bronchoscopic options for lung volume reduction in patients with severe emphysema, comparing their effectiveness and associated risks.
- It includes data from 25 randomized controlled trials involving over 4,000 patients, revealing that lung volume reduction surgery (LVRS) led to significant improvements in lung function and exercise capacity but also increased mid-term mortality risks.
- The findings suggest that while endobronchial valve (EBV) and endobronchial coil (EBC) procedures showed notable benefits similar to LVRS in lung function improvements, they also carry a higher risk of pneumothorax and slightly increased mortality, highlighting the need for further long-term survival studies for bronchoscopic interventions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!